Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Water Intelligence announces two acquisitions and new partnership in US

(Sharecast News) - Water Intelligence investors reacted positively to a flurry of news from the company on Wednesday, as it announced a trading update for the 2024 financial year, two acquisitions in the US, and a new partnership to bolster water damage prevention services. The AIM-listed company, which provides leak detection and remediation solutions for both potable and non-potable water, said 2024 results were in line with expectations, with revenues rising 10% to $83.3m and adjusted EBITDA up 12% at $15m.

Growth was driven by solid demand at the US corporate locations unit of its American Leak Detection (ALD) subsidiary - which makes up the bulk of its revenues - as well as a strong performance across international operations.

Water Intelligence also revealed that it has executed on two acquisitions to kick-off 2025: spending $1.2m on a plumbing company in Connecticut, Effective Plumbing; and $3m on an ALD franchise covering parts of Georgia and South Carolina.

"Both acquisitions are accretive to shareholder value and should drive accelerated revenue and profits for 2025," Water Intelligence said.

Meanwhile, it has agreed a strategic partnership with Chubb division StreamLabs Water, which provides water usage monitoring, leak detection and water shut-off solutions, and has a large presence in the US insurance market.

"With this partnership, ALD will launch a complementary preventive maintenance line of business that will synergistically drive organic growth in 2025 and beyond given our existing insurance channels," the company said.

Shares were up nearly 7% at 388.95p by 1100 GMT.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.